Scinovex
article Open AccessTop 10% cited

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

BMC Genomics · 2014 · Vol. 15(1) · pp. 190–190
John C. CastleMartin LöewerSebastian BoegelJos de GraafChristian BenderArbel D. TadmorValesca BoisguérinThomas BukurPatrick SornClaudia ParetMustafa DikenSebastian KreiterÖzlem TüreciUğur Şahin

Abstract

CT26 cells share molecular features with aggressive, undifferentiated, refractory human colorectal carcinoma cells. As CT26 is one of the most extensively used syngeneic mouse tumor models, our data provide a map for the rationale design of mode-of-action studies for pre-clinical evaluation of targeted- and immunotherapies.

Immunotherapy and Immune ResponsesCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersBiologyCancer researchKRASColorectal cancerMajor histocompatibility complexTranscriptomeCancerCarcinogenesisAntigenGenetics

MeSH terms

AnimalsAntigens, NeoplasmCarcinomaColonic NeoplasmsMice, Inbred BALB CProto-Oncogene Proteins p21(ras)Sequence Analysis, DNACyclin-Dependent Kinase Inhibitor p16Polymorphism, Single NucleotideCell Line, TumorMiceHigh-Throughput Nucleotide SequencingTranscriptome
Citations
381
FWCI
6.26
field-weighted impact
References
53
Percentile
97%
vs. same field & year
Citations per year
Cited by
Top 10 Challenges in Cancer Immunotherapy
Immunity · 2020 · 2,223 citations
References
GenePattern 2.0
Nature Genetics · 2006 · 2,105 citations
Epithelial–mesenchymal transitions in tumour progression
Nature reviews. Cancer · 2002 · 6,649 citations
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Proceedings of the National Academy of Sciences · 2005 · 55,472 citations
Signatures of mutational processes in human cancer
Nature · 2013 · 10,018 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.